Genetics and cardiomyopathy: Where are we now? | MDedge

Article Type

Changed

Mon, 09/10/2018 - 11:14

Display Headline

Genetics and cardiomyopathy: Where are we now?

Author(s)

Ross T. Murphy, MD

Randall C. Starling, MD, MPH, FACC, FESC

Article PDF

content_72_465.pdf

Author and Disclosure Information

Ross T. Murphy, MD
Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Randall C. Starling, MD, MPH
Head, Section of Heart Failure, Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Address: Randall T. Starling, MD, Department of Cardiovascular Medicine, F25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Dr. Starling has indicated that he has received grant or research support from the Novartis, Scios, Fujisawa, Acorn, and Guidant corporations, serves as a consultant for the Novartis and Acorn corporations, and is on the speakers’ bureaus of the Glaxo and Novartis corporations.

Issue

Cleveland Clinic Journal of Medicine - 72(6)

Publications

Cleveland Clinic Journal of Medicine

Topics

Page Number

465-466, 469-470, 472-473, 477-480, 482-483

Sections

Author(s)

Ross T. Murphy, MD

Randall C. Starling, MD, MPH, FACC, FESC

Author(s)

Ross T. Murphy, MD

Randall C. Starling, MD, MPH, FACC, FESC

Author and Disclosure Information

Ross T. Murphy, MD
Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Randall C. Starling, MD, MPH
Head, Section of Heart Failure, Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Address: Randall T. Starling, MD, Department of Cardiovascular Medicine, F25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Dr. Starling has indicated that he has received grant or research support from the Novartis, Scios, Fujisawa, Acorn, and Guidant corporations, serves as a consultant for the Novartis and Acorn corporations, and is on the speakers’ bureaus of the Glaxo and Novartis corporations.

Author and Disclosure Information

Ross T. Murphy, MD
Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Randall C. Starling, MD, MPH
Head, Section of Heart Failure, Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Address: Randall T. Starling, MD, Department of Cardiovascular Medicine, F25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Dr. Starling has indicated that he has received grant or research support from the Novartis, Scios, Fujisawa, Acorn, and Guidant corporations, serves as a consultant for the Novartis and Acorn corporations, and is on the speakers’ bureaus of the Glaxo and Novartis corporations.

Article PDF

content_72_465.pdf

Article PDF

content_72_465.pdf

Issue

Cleveland Clinic Journal of Medicine - 72(6)

Issue

Cleveland Clinic Journal of Medicine - 72(6)

Page Number

465-466, 469-470, 472-473, 477-480, 482-483

Page Number

465-466, 469-470, 472-473, 477-480, 482-483

Publications

Cleveland Clinic Journal of Medicine

Publications

Cleveland Clinic Journal of Medicine

Topics

Article Type

Display Headline

Genetics and cardiomyopathy: Where are we now?

Display Headline

Genetics and cardiomyopathy: Where are we now?

Sections

Disallow All Ads

Alternative CME

Consolidated Pubs: Do Not Show Source Publication Logo

Use ProPublica

Article PDF Media

Disable zoom

Off